Kim Tae Jun, Shin Hee-Young, Chang Yoosoo, Kang Mira, Jee Jaehwan, Choi Yoon-Ho, Ahn Hyeon Seon, Ahn Soo Hyun, Son Hee Jung, Ryu Seungho
Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Atherosclerosis. 2017 Jul;262:191-197. doi: 10.1016/j.atherosclerosis.2017.03.035. Epub 2017 Mar 28.
Although obesity and metabolic abnormalities are known risk factors for cardiovascular disease, the risk of cardiovascular disease among obese individuals without obesity-related metabolic abnormalities, referred to as metabolically healthy obese (MHO), remains unclear. We examined the association between body mass index categories and the development of subclinical carotid atherosclerosis in a cohort of metabolically healthy individuals.
We conducted a cohort study of 6453 men without subclinical carotid atherosclerosis or metabolic abnormalities at baseline, who underwent repeated health check-up examinations that included carotid ultrasound. A metabolically healthy state was defined as having no metabolic syndrome components and a homeostasis model assessment of insulin resistance <2.5. Subclinical carotid atherosclerosis was assessed using ultrasound.
During the follow-up period of 34,797.9 person-years, subclinical carotid atherosclerosis developed in 1916 participants. Comparing overweight and obese with normal weight participants, the multivariable adjusted hazard ratios (95% confidence intervals) for incident subclinical carotid atherosclerosis were 1.24 (1.12-1.38) and 1.54 (1.38-1.72), respectively. The association persisted after further adjustment for metabolic variables. This association was also evident in MHO men without abdominal obesity (waist circumference > 90 cm) and it did not differ across any clinically relevant subgroups evaluated.
In a large cohort study of strictly defined metabolically healthy participants, the MHO phenotype was associated with an increased risk of incident subclinical carotid atherosclerosis, providing evidence that the MHO phenotype is not protective from cardiovascular risk.
尽管肥胖和代谢异常是已知的心血管疾病风险因素,但在无肥胖相关代谢异常的肥胖个体(即代谢健康的肥胖者,MHO)中,心血管疾病风险仍不明确。我们在一组代谢健康个体中研究了体重指数类别与亚临床颈动脉粥样硬化发生之间的关联。
我们对6453名基线时无亚临床颈动脉粥样硬化或代谢异常的男性进行了队列研究,这些男性接受了包括颈动脉超声检查在内的多次健康检查。代谢健康状态定义为无代谢综合征组分且胰岛素抵抗的稳态模型评估<2.5。使用超声评估亚临床颈动脉粥样硬化。
在34797.9人年的随访期内,1916名参与者发生了亚临床颈动脉粥样硬化。与正常体重参与者相比,超重和肥胖参与者发生亚临床颈动脉粥样硬化的多变量调整风险比(95%置信区间)分别为1.24(1.12 - 1.38)和1.54(1.38 - 1.72)。在进一步调整代谢变量后,该关联仍然存在。这种关联在无腹型肥胖(腰围>90 cm)的MHO男性中也很明显,并且在评估的任何临床相关亚组中均无差异。
在一项对严格定义的代谢健康参与者的大型队列研究中,MHO表型与亚临床颈动脉粥样硬化发生风险增加相关,这表明MHO表型并不能预防心血管风险。